Darlene Taylor

Prof. Darlene Taylor

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2015 in F1000Research
Verified
Journal Article
Open access
PDF file
DTDarlene Taylor
Darlene Taylor
KHKristine Holthouser
Kristine Holthouser
JSJames Hugh Segars
James Hugh Segars
PLPhyllis C. Leppert
Phyllis C. Leppert
Uterine leiomyomas (fibroids) are the most prevalent medical problem of the female reproductive tract, but there are few non-surgical treatment options. Although many advances in the understanding of the molecular components of these tumors have occurred over the past five years, an effective pharmaceutical approach remains elusive. Further, there is currently no clinical method to distinguish a benign uterine leiomyoma from a malignant leiomyosarcoma prior to treatment, a pressing need given concerns about the use of the power morcellator for minimally invasive surgery. This paper reviews current studies regarding the molecular biology of uterine fibroids, discusses non-surgical approaches and suggests new cutting-edge therapeutic and diagnostic approaches.

5 September 2018 in ACS Chemical Biology
Verified
Journal Article
Closed access
JFJodie M. Fleming
Jodie M. Fleming
SYSusan Yeyeodu
Susan Yeyeodu
AMAshley McLaughlin
Ashley McLaughlin
DSDarren Schuman
Darren Schuman
DTDarlene Taylor
Darlene Taylor

Verified
Journal Article
Open access
PDF file
DTDarlene Taylor
Darlene Taylor
FJFriederike Jayes
Friederike Jayes
AHAlan J. House
Alan J. House
MOMelony A. Ochieng
Melony A. Ochieng
Temperature-triggered copolymers are proposed for a number of bio-applications but there is no ideal material platform, especially for injectable drug delivery. Options are needed for degradable biomaterials that not only respond to temperature but also easily accommodate linkage of active molecules. A first step toward realizing this goal is the design and synthesis of the novel materials reported herein. A multifunctional macromer, methacrylated hyperbranched polyglycerol (HPG-MA) with an average of one acrylate unit per copolymer, was synthesized and copolymerized with N-isopropylacrylamide (NIPAAm), hydroxyethyl methacrylate-polylactide (HEMAPLA) and acrylic acid (AAc). The potential to fully exploit the copolymers by modification of the multiple HPG hydroxyl groups will not be discussed here. Instead, this report focuses on the thermoresponsive, biocompatible, and degradation properties of the material. Poly(NIPAAm-co-HEMAPLA-co-AAc-co-HPG-MA) displayed increasing lower critical solution temperatures (LCST) as the HPG content increased over a range of macromer ratios. For the copolymer with the maximum HPG incorporation (17%), the LCST was ~30 °C. In addition, this sample showed no toxicity when human uterine fibroid cells were co-cultured with the copolymer for up to 72 h. This copolymer lost approximately 92% of its mass after 17 hours at 37 °C. Thus, the reported biomaterials offer attractive properties for the design of drug delivery systems where orthogonally triggered mechanisms of therapeutic release in relatively short time periods would be attractive.

1 October 2021 in Acta Biomaterialia
Verified
Journal Article
Closed access
RCRia D. Corder
Ria D. Corder
SGSashi V. Gadi
Sashi V. Gadi
RVRobert B. Vachieri
Robert B. Vachieri
FJFriederike L. Jayes
Friederike L. Jayes
JCJohn M. Cullen
John M. Cullen
DTDarlene Taylor
Darlene Taylor

31 January 2023 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
RCRia D. Corder
Ria D. Corder
RVRobert B. Vachieri
Robert B. Vachieri
MMMegan E. Martin
Megan E. Martin
DTDarlene Taylor
Darlene Taylor
JFJodie M. Fleming
Jodie M. Fleming
SKSaad A. Khan
Saad A. Khan
Extracellular matrix (ECM) rigidity has been shown to increase the invasive properties of breast cancer cells, promoting transformation and metastasis through mechanotransduction. Reducing ECM stiffness via enzymatic digestion could be a promising approach to slowing breast cancer development by de-differentiation of breast cancer cells to less aggressive phenotypes and enhancing the effectiveness of existing chemotherapeutics via improved drug penetrance throughout the tumor. In this study, we examine the effects of injectable liberase (a blend of collagenase and thermolysin enzymes) treatments on the linear and nonlinear rheology of allograft 4T1 mouse mammary tumors. We perform two sets of in vivo mouse studies, in which either one or multiple treatment injections occur before the tumors are harvested for rheological analysis. The treatment groups in each study consist of a buffer control, free liberase enzyme in buffer, a thermoresponsive copolymer called LiquoGel (LQG) in buffer, and a combined, localized injection of LQG and liberase. All tumor samples exhibit gel-like linear rheological behavior with the elastic modulus significantly larger than the viscous modulus and both independent of frequency. Tumors that receive a single injection of localized liberase have significantly lower tumor volumes and lower tissue moduli at both the center and edge compared to buffer- and free liberase-injected control tumors, while tissue viscoelasticity remains relatively unaffected. Tumors injected multiple times with LQG and liberase also have lower tissue volumes but possess higher tissue moduli and lower viscoelasticities compared to the other treatment groups. We propose that a mechanotransductive mechanism could cause the formation of smaller but stiffer tumors after repeated, localized liberase injections. Large amplitude oscillatory shear (LAOS) experiments are also performed on tissues from the multiple injection study and the results are analyzed using MITlaos. LAOS analysis reveals that all 4T1 tumors from the multiple injection study exhibit nonlinear rheological behavior at high strains and strain rates. Examination of the Lissajous-Bowditch curves, Chebyshev coefficient ratios, elastic moduli, and dynamic viscosities demonstrate that the onset and type of nonlinear behavior is independent of treatment type and elastic modulus, suggesting that multiple liberase injections do not affect the nonlinear viscoelasticity of 4T1 tumors.

12 April 2013 in Tetrahedron Letters
Verified
Journal Article
Closed access
KLKhoa Le
Khoa Le
LCLokendra B. Chand
Lokendra B. Chand
CGColette Griffin
Colette Griffin
AWAlfred L. Williams
Alfred L. Williams
DTDarlene Taylor
Darlene Taylor